• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

Hanwha’s Kim Seung-youn and Kim Dong-kwan: Will the Father-Son 'Parallel Theory' Be Completed?

신혜주 기자

hjs0509@fntimes.com

기사입력 : 2025-04-07 13:22

◇ Father in Petrochemicals, Son in Defense: 'The 41-Year Old's Bold Move'
◇ Tackling 'Succession Funds' Allegations with Bold Stock Transfers

From Left: Kim Dong-kwan, Vice Chairman of Hanwha Group, and Kim Seung-youn, Chairman of Hanwha Group

From Left: Kim Dong-kwan, Vice Chairman of Hanwha Group, and Kim Seung-youn, Chairman of Hanwha Group

[Korea Financial Times, Shin Haeju] Could it be the inherited managerial DNA?

Kim Dong-kwan, Vice Chairman of Hanwha Group, demonstrates leadership and decisiveness that closely resemble those of his father, Chairman Kim Seung-youn. In fact, Vice Chairman Kim is retracing the path his father walked 30 years ago.

The father-son duo, Kim Seung-youn and Kim Dong-kwan, both made pivotal moves at the age of 41. Despite living in different eras, their lives reflect a parallel theory of shared destiny.

Born in October 1983, Vice Chairman Kim Dong-kwan turned 41 this year. Last month, Hanwha Aerospace, under his leadership, announced plans for a capital increase through rights issuance. The move aims to expand overseas production bases and elevate the company to a top-tier position in global defense, shipbuilding, and aerospace industries.

Out of the KRW 3.6 trillion raised through the rights issuance, KRW 2.4 trillion will be allocated overseas. Specifically, KRW 1 trillion will be used to establish local factories for enhancing overseas defense production capabilities, KRW 600 billion for joint ventures (JVs) with foreign defense companies, and KRW 800 billion for acquiring stakes in overseas shipbuilding companies.

Among these allocations, approximately KRW 30 billion is required immediately this year to set up a JV with a Saudi Arabian defense company. Additional investments will follow sequentially: KRW 1.31 trillion in 2026, KRW 580 billion in 2027, and KRW 480 billion in 2028. It will take about three to four more years to fully utilize the funds raised through the rights issuance.

Chairman Kim Seung-youn also was reshaping Hanwha Group at the age of 41. In 1994, he declared a "second founding" of the group and diversified its business portfolio from explosives and heavy industries into petrochemicals and services. He acquired Hanyang Chemical (now Hanwha Solutions Chemical Division) and bought foreign stakes in Kyungin Energy (now Hanwha Energy), transforming Hanwha into one of Korea’s leading petrochemical companies.

Despite opposition from those around him, Chairman Kim boldly acquired Hanyang Chemical, which was struggling with Tens of billions of won in losses at the time. Within a year, he turned the company profitable.

He also rebranded Korea Explosives Group as Hanwha Group and reorganized all affiliates by 1995. Hanwha’s assets grew from KRW 500 billion in 1981 to KRW 5 trillion in 1991 and further to KRW 8 trillion by 1995.

The dramatic transformation from explosives to petrochemicals over the past 30 years has continued, evolving into a global top-tier defense, shipbuilding, and aerospace powerhouse.

This is the background behind Hanwha Aerospace’s move to carry out the largest rights offering ever by a Korean company.

The "parallel theory" between Kim Seung-youn and Kim Dong-kwan appears to be nearing completion. In response to market speculation that Hanwha Aerospace's rights issuance might be linked to family succession plans, Chairman Kim Seung-youn last month transferred nearly half of his stake in Hanwha Corporation—the group’s holding company—to his three sons: Vice Chairman Kim Dong-kwan, President Kim Dong-won, and Executive Vice President Kim Dong-sun. With this transfer, the three brothers now collectively hold shares in Hanwha Corporation, effectively finalizing the group's succession process.

Hanwha Group clarified that "the stock transfer was intended to ensure that Hanwha Aerospace's rights issuance is not associated with succession plans," adding that "the acquisition of Hanwha Ocean shares by Hanwha Aerospace is also unrelated to succession but rather part of a strategic initiative for global land-sea-air defense package operations."

Shin Haeju (hjs0509@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 LG Chem Petrochemicals Face Losses Despite NCC Restart; Advanced Materials Recovering Petrochemicals is once again LG Chem’s main concern. While earnings at its battery subsidiary and advanced materials business are improving, its petrochemicals division, which returned to profit in the first half, is expected to slip back into the red in the second half. The No. 2 naphtha cracking center (NCC) plant in Yeosu, idled for about six months, has resumed operations. But a profit recovery looks difficult as the negative inventory lag effect from falling feedstock prices and higher logistics costs weigh on results.According to financial data provider FnGuide on the 22th, the consensu 2 Hanwha Systems Raises KRW 3.4 Trillion as It Winds Down ‘Bridge’ Role in Hanwha Ocean Deal Hanwha Systems is raising KRW 3.4 trillion through a price return swap (PRS) on its Hanwha Ocean shares and the sale of its stake in the Philly shipyard in the United States. Both assets came out of Hanwha Systems’ efforts to back the Hanwha Group’s push to strengthen its shipbuilding business. The company is now expected to end its “bridge” role and concentrate on strengthening its core business through capital reallocation.According to the investment banking (IB) industry on Oct. 20, Hanwha Systems recently decided to transfer all 22,169,660 of its Hanwha Ocean common shares to Kiwoom Se 3 Hanmi Pharm Hit by Shareholder Feud, Rights Return; Next Obesity Drug Key to Rebound Hanmi Pharm is facing a double blow, a dispute among its major shareholders and the return of rights to a key pipeline asset, and has slipped into a valuation discount.While solid core profitability provides a cushion, further out-licensing of follow-up obesity drugs and a resolution of governance risk are expected to be the main turning points for a revaluation.Inheritance Tax Sparked the Feud, Now a KRW 60 Billion LawsuitHanmi Pharmaceutical Group’s operating environment is clouded from every direction, industry sources said on Oct. 18. The governance risk began after the death of founder L
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ‘순대’가 경제용어라고? 순(純)대외자산, 한국의 진짜 해외자산은 얼마일까?
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략

FT도서

더보기